TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases

Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression

(2011) Joshua D. Schiffman et al.   BRITISH JOURNAL OF HAEMATOLOGY

p53 Lesions in Leukemic Transformation

(2011) Ashot Harutyunyan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advances in the understanding of MYC-induced lymphomagenesis

(2010) Kay Klapproth et al.   BRITISH JOURNAL OF HAEMATOLOGY

The RB (pRb2/p16) and p53 (p14/p53/p21) Tumor-suppressor Pathways in Endemic Burkitt Lymphoma

(2010) Sam Kalungi et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis

(2010) Mei Liang et al.   MODERN PATHOLOGY

Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?

(2009) Mark Wade et al.   MOLECULAR CANCER RESEARCH

High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 (MDM4) as an Amplification Target Exclusive of MDM2 and TP53

(2008) A. Veerakumarasivam et al.   CLINICAL CANCER RESEARCH

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study

(2008) H A Poirel et al.   LEUKEMIA

Regulation of MDMX Expression by Mitogenic Signaling

(2008) D. M. Gilkes et al.   MOLECULAR AND CELLULAR BIOLOGY

Apoptotic signaling by c-MYC

(2008) B Hoffman et al.   ONCOGENE